Australia Interventional Cardiology Devices Market Size & Outlook

The interventional cardiology devices market in Australia is expected to reach a projected revenue of US$ 582.1 million by 2033. A compound annual growth rate of 8.2% is expected of Australia interventional cardiology devices market from 2025 to 2033.
Revenue, 2024 (US$M)
$287.5
Forecast, 2033 (US$M)
$582.1
CAGR, 2025 - 2033
8.2%
Report Coverage
Australia

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Australia interventional cardiology devices market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Related Markets

Australia interventional cardiology devices market highlights

  • The Australia interventional cardiology devices market generated a revenue of USD 287.5 million in 2024 and is expected to reach USD 582.1 million by 2033.
  • The Australia market is expected to grow at a CAGR of 8.2% from 2025 to 2033.
  • In terms of segment, coronary stents was the largest revenue generating products in 2024.
  • Accessory Devices is the most lucrative products segment registering the fastest growth during the forecast period.


Interventional cardiology devices market data book summary

Market revenue in 2024USD 287.5 million
Market revenue in 2033USD 582.1 million
Growth rate8.2% (CAGR from 2025 to 2033)
Largest segmentCoronary stents
Fastest growing segmentAccessory Devices
Historical data2021 - 2023
Base year2024
Forecast period2025 - 2033
Quantitative unitsRevenue in USD million
Market segmentationCoronary Stents, PTCA Balloon Catheters, Intravascular Imaging Catheters and Pressure Guidewires, Accessory Devices
Key market players worldwideAbbott Laboratories, Medtronic PLC, Boston Scientific Corp, Koninklijke Philips NV, Cardinal Health Inc, Terumo Corp, Teleflex Inc, B. Braun, Biosensors, BIOTRONIK, Asahi Intecc Co Ltd, Cook Medical, Merit Medical Systems Inc, Haemonetics Corp, Vascular Solutions, Zeon Corp, Alvimedica, Meril Life, Medinol


Other key industry trends

  • In terms of revenue, Australia accounted for 2.7% of the global interventional cardiology devices market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
  • In Asia Pacific, China interventional cardiology devices market is projected to lead the regional market in terms of revenue in 2033.
  • China is the fastest growing regional market in Asia Pacific and is projected to reach USD 1,191.6 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Interventional Cardiology Devices Market Companies

Name Profile # Employees HQ Website
Medinol View profile 251-500 Tel Aviv, Tel Aviv, Israel, Asia http://www.medinol.com/
Alvimedica View profile 101-250 Çatalca, Istanbul, Turkey, Europe http://alvimedica.com
Zeon Corp View profile 4722 Shin Marunouchi Center Building, 1-6-2 Marunouchi, Chiyoda-ku, Tokyo, Japan, 100-8246 http://www.zeon.co.jp
Meril Life View profile 1001-5000 Vapi, Daman and Diu, India, Asia https://www.merillife.com/
Asahi Intecc Co Ltd View profile 10364 1703 Wakita-cho, Nagoya, Japan http://www.asahi-intecc.co.jp
Haemonetics Corp View profile 3657 125 Summer Street, Boston, MA, United States, 02110 https://www.haemonetics.com
Merit Medical Systems Inc View profile 6950 1600 West Merit Parkway, South Jordan, UT, United States, 84095 https://www.merit.com
Vascular Solutions View profile 501-1000 Minneapolis, Minnesota, United States, North America http://www.vascularsolutions.com
BIOTRONIK View profile 5001-10000 Berlin, Berlin, Germany, Europe https://www.biotronik.com/de-de
Biosensors View profile 1001-5000 Singapore, Central Region, Singapore, Asia http://biosensors.com
Cook Medical View profile 10001+ Bloomington, Indiana, United States, North America http://www.cookmedical.com
B. Braun View profile 10001+ Chapeltown, Sheffield, United Kingdom, Europe https://www.bbraun.co.uk
Cardinal Health Inc View profile 48000 7000 Cardinal Place, Dublin, OH, United States, 43017 https://www.cardinalhealth.com
Terumo Corp View profile 30207 2-44-1 Hatagaya, Shibuya-ku, Tokyo, Japan, 151-0072 https://www.terumo.com
Teleflex Inc View profile 14500 550 East Swedesford Road, Suite 400, Wayne, PA, United States, 19087 https://www.teleflex.com
Boston Scientific Corp View profile 48000 300 Boston Scientific Way, Marlborough, MA, United States, 01752-1234 https://www.bostonscientific.com
Medtronic PLC View profile 95000 Lower Hatch Street, 20 On Hatch, Dublin, Ireland, 2 https://www.medtronic.com
Koninklijke Philips NV View profile 73712 Philips Center, Amstelplein 2, Amsterdam, Netherlands, 1096 BC https://www.philips.com
Abbott Laboratories View profile 114000 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 https://www.abbottinvestor.com

Australia interventional cardiology devices market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to interventional cardiology devices market will help companies and investors design strategic landscapes.


Coronary stents was the largest segment with a revenue share of 54.61% in 2024. Horizon Databook has segmented the Australia interventional cardiology devices market based on coronary stents, ptca balloon catheters, intravascular imaging catheters and pressure guidewires, accessory devices covering the revenue growth of each sub-segment from 2021 to 2033.


In Australia, the increasing adoption of PCI procedures drives the interventional cardiology devices market. Government initiatives and healthcare infrastructure investments contribute to the expansion of the market, facilitating improved access to innovative medical technologies and enhancing patient outcomes in cardiovascular care across the country.

In Australia, growth of interventional cardiology devices presents both opportunities and challenges for healthcare professionals. With advancements in technology and increasing demand for minimally invasive procedures, there is a growing need for specialized training programs tailored to the Australian healthcare landscape.

These training programs aim to prepare healthcare providers with the necessary skills and expertise to effectively utilize interventional cardiology devices. They focus on educating professionals on the latest techniques, procedures, and technologies, ensuring they are proficient in delivering high-quality care to patients.

Reasons to subscribe to Australia interventional cardiology devices market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Australia interventional cardiology devices market databook

  • Our clientele includes a mix of interventional cardiology devices market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Australia interventional cardiology devices market , including forecasts for subscribers. This country databook contains high-level insights into Australia interventional cardiology devices market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Australia interventional cardiology devices market size, by products, 2021-2033 (US$M)

Australia Interventional Cardiology Devices Market Outlook Share, 2024 & 2033 (US$M)

Australia interventional cardiology devices market size, by products, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online